Vol. 88 No. 12 (2003): December, 2003 : Letters to the Editor
Published
2003-01-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
Article Usage
Online Views
160
PDF Downloads
69
Statistics from Altmetric.com
No Data
How to Cite
1.
X Agirre, A Fontalba, EJ Andreu, MD Odero, MJ Larrayoz, C Montiel, MJ Calasanz, JL Fernandez-Luna, F Prosper. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Haematologica 2003;88(12):1425-1426; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is
required. For
information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
